New Delhi, Oct 3 (PTI) Pharmaceutical company Rubicon Research is set to raise Rs 1,377.50 crore through its initial public offering (IPO), which will open for subscription on October 9.

According to the Red Herring Prospectus (RHP), the issue will close on October 13, while the bidding for anchor investors will open for a day on October 8.

The company has fixed a price band at Rs 461 to Rs 485 per share for its maiden public offering.

Rubicon Research's proposed IPO comprises a fresh issue of equity shares worth Rs 500 crore, along with an offer-for-sale (OFS) of shares valued at Rs 877.5 crore by the promoter, General Atlantic Singapore RR Pte Ltd.

Proceeds from the fresh issue amounting to Rs 310 crore will be used for debt repayment, with a portion allocated for inorganic growth th

See Full Page